Dendritic Cell Vaccine for the treatment of Chronic Myeloid Leukemia
Rania Abdalla Hussein Abou El Nour;
Abstract
Chronic myeloid leukemia (CML) is defined by a unique molecular event, the BCR-ABL oncogene. The BCR-ABL oncogene presents a good opportunity to develop therapeutic strategies using vaccination against a truly tumor-specific antigen that is also
Other data
| Title | Dendritic Cell Vaccine for the treatment of Chronic Myeloid Leukemia | Other Titles | مصل من الخلايا الفرعية لعلاج اللوكيميا الميلودية المزمنة | Authors | Rania Abdalla Hussein Abou El Nour | Keywords | Dendritic Cell Vaccine for the treatment of Chronic Myeloid Leukemia | Issue Date | 2009 | Description | Chronic myeloid leukemia (CML) is defined by a unique molecular event, the BCR-ABL oncogene. The BCR-ABL oncogene presents a good opportunity to develop therapeutic strategies using vaccination against a truly tumor-specific antigen that is also |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 94598r2431.pdf | 218.3 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.